1) Non-hyperleukocytic acute leukemia Prognosis
非高白细胞性急性白血病
2) hyperleukocytosis acute myelogenous leukemia
高白细胞性急性非淋巴细胞性白血病
1.
Efficacy of LD-HA combined with regular chemotherapy in treatment of hyperleukocytosis acute myelogenous leukemia;
LD-HA联合诱导治疗高白细胞性急性非淋巴细胞性白血病
3) hyperleukocytic acute leukemia
高白细胞性急性白血病
1.
Study on the prognosis of 21 patients with hyperleukocytic acute leukemia;
高白细胞性急性白血病21例预后分析
4) acute non-lymphocytic leukemia
急性非淋巴细胞白血病
1.
Clinic analysis of childhood acute non-lymphocytic leukemia;
儿童急性非淋巴细胞白血病临床分析
2.
The aim of this study was to evaluate the safety and efficacy of allogeneic hematopoietic peripheral blood stem cell transplantation (allo-PBHSCT) for post-operative therapy of acute non-lymphocytic leukemia (ANLL) patient complicated with renal cell carcinoma (RCC).
本研究探索异基因造血干细胞移植治疗急性非淋巴细胞白血病合并肾细胞癌切除术后患者的有效性与安全性。
3.
To explore the expression of livin gene in acute non-lymphocytic leukemia(ANLL)cells and its clinical significance,the mRNA level of livin gene in 46 ANLL adult patients were measured by using reverse transcription polymerase chain reaction(RT-PCR).
为了探讨急性非淋巴细胞白血病(ANLL)原代细胞livin基因表达及临床意义,采用逆转录-聚合酶链反应(RT-PCR)检测46例急性非淋巴细胞白血病患者livin基因mRNA表达水平,以10名健康人为正常对照,以HL-60细胞株为阳性对照。
5) Acute non-lymphocytic leukemia cell lines
急性非淋巴白血病细胞
6) Acute nonlymphoblastic leukemia
急性非淋巴细胞白血病
1.
From October 1995 to August 1988,58 untreated patients with acute nonlymphoblastic leukemia(ANLL) ranging in age from 14 to 65 years were randomized to receive MA( Mitoxantrone 10mg/day iv for 3 days, cytosine arabinoside 150mg/day iv for 7 days or DA(daunorubicin 40 mg/m\+2/day iv for 3days , cytosine arabinoside 150 mg/day iv for 7 days), 16 of 28 caces (57.
本文报告MA和DA方案治疗急性非淋巴细胞白血病 (ANLL) 5 8例 ,其中 2 8例用MA方案 ,CR16例 (5 7 1% ) ;30例用DA方案 ,CR18例 (6 0 % ) ,两种方案CR率相似 (P >0 0 5 )。
补充资料：细胞的多样性眼虫
[图]
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条